AU2511997A - Composition containing milnacipran and idazoxan for use as combined pharmaceutical preparation - Google Patents

Composition containing milnacipran and idazoxan for use as combined pharmaceutical preparation

Info

Publication number
AU2511997A
AU2511997A AU25119/97A AU2511997A AU2511997A AU 2511997 A AU2511997 A AU 2511997A AU 25119/97 A AU25119/97 A AU 25119/97A AU 2511997 A AU2511997 A AU 2511997A AU 2511997 A AU2511997 A AU 2511997A
Authority
AU
Australia
Prior art keywords
idazoxan
composition containing
pharmaceutical preparation
combined pharmaceutical
containing milnacipran
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU25119/97A
Other languages
English (en)
Inventor
Francis Colpaert
Thierry Imbert
Wounter Koek
Marc Marien
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pierre Fabre Medicament SA
Original Assignee
Pierre Fabre Medicament SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pierre Fabre Medicament SA filed Critical Pierre Fabre Medicament SA
Publication of AU2511997A publication Critical patent/AU2511997A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU25119/97A 1996-03-25 1997-03-25 Composition containing milnacipran and idazoxan for use as combined pharmaceutical preparation Abandoned AU2511997A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR9603674A FR2746314B1 (fr) 1996-03-25 1996-03-25 Produit contenant du milnacipran et de l'idazoxan comme preparation pharmaceutique combinee
FR9603674 1996-03-25
PCT/FR1997/000522 WO1997035574A1 (fr) 1996-03-25 1997-03-25 Produit contenant du milnacipran et de l'idazoxan comme preparation pharmaceutique combinee

Publications (1)

Publication Number Publication Date
AU2511997A true AU2511997A (en) 1997-10-17

Family

ID=9490503

Family Applications (1)

Application Number Title Priority Date Filing Date
AU25119/97A Abandoned AU2511997A (en) 1996-03-25 1997-03-25 Composition containing milnacipran and idazoxan for use as combined pharmaceutical preparation

Country Status (3)

Country Link
AU (1) AU2511997A (fr)
FR (1) FR2746314B1 (fr)
WO (1) WO1997035574A1 (fr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6602911B2 (en) 2001-11-05 2003-08-05 Cypress Bioscience, Inc. Methods of treating fibromyalgia
US6635675B2 (en) 2001-11-05 2003-10-21 Cypress Bioscience, Inc. Method of treating chronic fatigue syndrome
FR2851163B1 (fr) 2003-02-14 2007-04-27 Utilisation de l'enantiomere dextrogyre du milnacipran pour la preparation d'un medicament
MXPA05008652A (es) 2003-02-14 2005-10-18 Pf Medicament Uso del enantiomero (1s,2r) de milnacipran para la preparacion de un medicamento.
FR2861299B1 (fr) 2003-10-28 2006-01-27 Pf Medicament Compositions pharmaceutiques a base de derives d'idasoxan sous formes polymorphes
US8476307B2 (en) 2003-10-28 2013-07-02 Pierre Fabre Medicament Pharmaceutical composition based on idazoxan, salts, hydrates or polymorphs thereof
US7595335B2 (en) 2003-10-28 2009-09-29 Pierre Fabre Medicament Pharmaceutical composition based on idazoxan, salts, hydrates or polymorphs thereof
US20080269306A1 (en) * 2004-12-27 2008-10-30 Alpha 2 Pharmaceutica Ab Antidepressant Medicament Comprising Idazoxan and a Selective Serotonin Reuptake Inhibitor
US8865937B2 (en) 2009-11-06 2014-10-21 Mahendra G. Dedhiya Crystalline forms of (1S,2R)-2-(amino methyl)-N,N-diethyl-1-phenyl cyclopropane carboxamide
US20120289744A1 (en) 2010-11-03 2012-11-15 Arch Pharmalabs Limited Process for preparing optically pure milnacipran and its pharmaceutically acceptable salts

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5124346A (en) * 1991-04-23 1992-06-23 Pfizer Inc. Synergistic combinations in the treatment of anxiety
US5492907A (en) * 1992-12-09 1996-02-20 The United States Of America As Represented By The Department Of Health & Human Services Antipsychotic composition and method of treatment
CA2134038C (fr) * 1994-06-16 1997-06-03 David Taiwai Wong Potentialisation des effets de medicaments

Also Published As

Publication number Publication date
FR2746314A1 (fr) 1997-09-26
WO1997035574A1 (fr) 1997-10-02
FR2746314B1 (fr) 1998-06-12

Similar Documents

Publication Publication Date Title
AU3445697A (en) New use of xylitol and pharmaceutical compositions therefor
HK1105580A1 (en) Use of isoflavone compounds in the manufacture of medicament and composition comprising the same
HUP9701169A3 (en) Cycloalkano-pyridine derivatives, intermediates, preparation and use thereof, pharmaceutical compositions containing these compounds
AU1618697A (en) Novel compounds and pharmaceutical use thereof
HUP0200831A2 (en) Novel pharmaceutical composition containing amoxycillin and its use
HUP0003526A2 (en) The use of delayed and/or sustained release vitamin d formulations and pharmaceutical compositions containing d-vitamins
AU5136998A (en) Medicinal composition
HUP0000733A3 (en) Aminoguanidines and alkoxyguanidines as and pharmaceutical compositions containing them
AU5880498A (en) New benzolactam derivatives and medicinal compositions containing the same
HUP9904694A3 (en) Spiropyrrolidine derivatives, their use and pharmaceutical compositions containing them
AU9018898A (en) Phosphazole-containing nucleoside analogs, related compounds, pharmaceutical compositions thereof, and their use in in vitro medicinal treatments
AU5856898A (en) Heteroarylsulfonamide derivatives and pharmaceutical compositions containing them
AU5565099A (en) Pharmaceutical compositions and methods for use
AP2001002371A0 (en) Streptogramin derivatives preparation and compositions containing them
HUP0001858A3 (en) Bi-aromatic compounds and pharmaceutical and cosmetic compositions containing same and the use of the compounds
AU2511997A (en) Composition containing milnacipran and idazoxan for use as combined pharmaceutical preparation
AU2030297A (en) Taxoids, preparation thereof and pharmaceutical compositions containing same
IL125284A0 (en) Cephem compounds pharmaceutical compositions containing the same and use thereof
HUP0101733A3 (en) Pharmaceutical compositions containing sulfonyl-dipeptides and their use
HUP9800631A3 (en) 4-aminotetrahydrobenzisoxazole or -isothiazole derivatives, pharmaceutical compositions containing them and their use for the preparation of pharmaceutical compositions
AU3460897A (en) Medicinal compositions
ZA961983B (en) Bicyclic compounds, preparation thereof and use in pharmaceutical compositions.
AU2104900A (en) Composition used as medicine and use of same for obtaining medicine for anaesthesia, in particular analgesic medicine
AU6720698A (en) Pharmaceutical compositions containing colostrum and the use of colostrum for the treatment of hair loss
AU2513899A (en) Mixture and pharmaceutical composition comprising z-4-hydroxytamoxifen and cyclodextrin